India, March 3 -- (Adds Outlook, stock movement)
For the full-year 2025, Surgery Partners, Inc. (SGRY) expects an increase in revenue from the prior year.
For the 12-mponth period, the company expects adjusted EBITDA of $555 to $565 million. Annual revenue is anticipated to be in the range of $3.30 to $3.45 billion, compared with analysts' forecast of $3.39 billion. For the full-year 2024, Surgery Partners has recorded adjusted EBITDA of $508.2 million, on revenue of $3.1 billion.
As of this writing, SGRY is up 3.82 percent at $25 in the pre-market trade on the Nasdaq.
Q4 Result:
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
Below are the earnings highlights for Surgery Partners.
Earnings: -$108...